Conclusions Telomerase activity could be a useful marker for evaluating malignant clonal proliferation, and it is hopeful to become a new molecular target for monitoring minimal residual leukemia.
结论端粒酶活化与肿瘤的恶性转化密切相关，可作为恶性血液病恶性克隆增殖的分子标志，有希望成为监测微量残留白血病的一个新指标。
Clonal immunoglobulin heavy chain gene rearrangement can be used as a effective diagnostic molecular marker for B-NHL.
克隆性免疫球蛋白重链基因重排检测可以作为诊断恶性B细胞性非霍奇金淋巴瘤的有效分子标志。
应用推荐